Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT03146520
Eligibility Criteria:
Inclusion criteria:
* sample information is complete, including sample number, gender, family history, stage of cancer, treatment history, and other disease information
* the CRC patient who has not any treatment (surgery, chemotherapy, or radiation)
* non-CRC patient who has not received any treatment (surgery, chemotherapy, or radiation) within the last 6 months
* all of above conditions are satisfied, and any one of below can be applicable; 1) confirm to be CRC with colonoscopy and/or pathological examination, 2) confirm to be inflammatory or ulcerative bowel diseases or benign hyperplastic polyp, 3) confirm to be gastrointestinal or liver cancers who are not CRC, 4) schedule to receive colonoscopy and additional confirmation test for CRC with agreement to provide the test results.
Exclusion criteria: any one of below can be applicable;
* the patient information is not complete and/or does not satisfy inclusion criteria
* the sample information is not complete and/or does not satisfy inclusion criteria
* the CRC patient who has history of colorectal cancer surgery, chemotherapy, or any other treatment
* non-CRC patient who received any chemotherapy within the last 6 months
* the patient who has limited ability or are vulnerable to accept clinical trial agreement
* the patient who is judged as not suitable for clinical trial including a psychiatric disorder by a physician
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT03146520
Study Brief:
Protocol Section:
NCT03146520